The Alzheimer’s Association has announced a new $7 million investment in clinical trials targeting brain inflammation — but with a twist.
Four cutting-edge studies will receive $1 million each over 2 years, but the remainder will go to the clinical trial that demonstrates the most promise for treating Alzheimer’s disease.
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.